Search by Drug Name or NDC

NDC 53002-1719-03 Sildenafil 20 mg/1 Details

Sildenafil 20 mg/1

Sildenafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is SILDENAFIL CITRATE.

MedlinePlus Drug Summary

Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Revatio) is used to improve the ability to exercise in adults with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Children should not usually take sildenafil, but in some cases, a doctor may decide that sildenafil (Revatio) is the best medication to treat a child's condition. Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily. If you are taking sildenafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Sildenafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Related Packages: 53002-1719-03
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sildenafil

Product Information

NDC	53002-1719
Product ID	53002-1719_6a4d64ad-561c-4f3f-b078-822c9606e875
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Sildenafil
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sildenafil
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	20
Active Ingredient Units	mg/1
Substance Name	SILDENAFIL CITRATE
Labeler Name	RPK Pharmaceuticals, Inc.
Pharmaceutical Class	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA078380
Listing Certified Through	2024-12-31

Package

NDC 53002-1719-03 (53002171903)

Pricing Information	N/A
NDC Package Code	53002-1719-3
Billing NDC	53002171903
Package	30 TABLET, FILM COATED in 1 BOTTLE (53002-1719-3)
Marketing Start Date	2018-10-01
NDC Exclude Flag	N